We are live on ! Find out more
Parallax Volatility Advisers

Parallax Volatility Advisers Portfolio holdings

AUM $38.6B
1-Year Est. Return 45.89%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+45.89%
3 Year Est. Return
+130.57%
5 Year Est. Return
+159.2%
10 Year Est. Return
+646.93%
AUM
$73.6B
AUM Growth
+$13B
Cap. Flow
+$9.23B
Cap. Flow %
12.54%
Top 10 Hldgs %
62.59%
Holding
5,549
New
2,351
Increased
689
Reduced
564
Closed
493

Sector Composition

Rank Sector Weight
1 Financials 0.85%
2 Technology 0.72%
3 Consumer Discretionary 0.46%
4 Industrials 0.43%
5 Communication Services 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAX
3676
DELISTED
J. Alexander's Holdings, Inc.
JAX
$20K ﹤0.01%
+2,016
New +$20.9K
I
3677
DELISTED
INTELSAT S. A.
I
$20K ﹤0.01%
+5,754
New +$25.7K
PKD
3678
DELISTED
Parker Drilling Company
PKD
$20K ﹤0.01%
+1,355
New +$20.9K
TRCB
3679
DELISTED
Two River Bancorp
TRCB
$20K ﹤0.01%
+1,092
New +$20.5K
AREX
3680
DELISTED
Approach Resources Inc.
AREX
$20K ﹤0.01%
+6,804
New +$16.8K
MACK
3681
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$20K ﹤0.01%
+2,509
New +$23.4K
PHIIK
3682
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$20K ﹤0.01%
+1,764
New +$21K
BOX icon
3683
CALL
Box
BOX
$4.4B
$19K ﹤0.01%
900
MTNB icon
3684
Matinas BioPharma
MTNB
$1.86M
$19K ﹤0.01%
+323
New +$20.8K
NATR icon
3685
Nature's Sunshine
NATR
$360M
$19K ﹤0.01%
+1,638
New +$18.6K
PROV icon
3686
Provident Financial
PROV
$112M
$19K ﹤0.01%
+1,008
New +$19.4K
TRAK icon
3687
ReposiTrak
TRAK
$159M
$19K ﹤0.01%
+1,974
New +$21.7K
SCTL
3688
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$19K ﹤0.01%
+2,295
New +$18.8K
P
3689
CALL
DELISTED
Pandora Media Inc
P
$19K ﹤0.01%
4,000
-170,000
-98% -$1.02M
CASC
3690
DELISTED
Cascadian Therapeutics, Inc.
CASC
$19K ﹤0.01%
+5,208
New +$21.3K
ASCMA
3691
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$19K ﹤0.01%
+1,680
New +$20.2K
IMDZ
3692
DELISTED
Immune Design Corp.
IMDZ
$19K ﹤0.01%
+4,914
New +$26.8K
ACAD icon
3693
Acadia Pharmaceuticals
ACAD
$4.65B
$18K ﹤0.01%
607
-10,875
-95% -$348K
AVXL icon
3694
Anavex Life Sciences
AVXL
$292M
$18K ﹤0.01%
+5,670
New +$22.3K
MBCN
3695
DELISTED
Middlefield Banc Corp
MBCN
$18K ﹤0.01%
+756
New +$17.6K
MVIS icon
3696
Microvision
MVIS
$85.2M
$18K ﹤0.01%
+756
New +$21.8K
PKBK icon
3697
Parke Bancorp
PKBK
$401M
$18K ﹤0.01%
+1,067
New +$18.7K
PVBC
3698
DELISTED
Provident Bancorp
PVBC
$18K ﹤0.01%
+1,358
New +$16.1K
SYRS
3699
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$18K ﹤0.01%
+189
New +$25.4K
ELVT
3700
DELISTED
Elevate Credit, Inc.
ELVT
$18K ﹤0.01%
+2,352
New +$17.4K

Similar funds

Parallax Volatility Advisers's Q4 2017 Portfolio in Review

As of Q4 2017, Parallax Volatility Advisers held 5,549 positions worth $73.6B, up 21% from $60.6B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Parallax Volatility Advisers deployed $9.23B of net new capital in Q4 2017, opening 2,351 new positions and adding to 689 existing holdings. Its largest new stake was iShares MSCI Japan ETF: 520,841 shares worth $31.2M.

By sector, the portfolio is most concentrated in Financials at 0.85% of assets, up from 0.69% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $227M trimmed.

  • Parallax Volatility Advisers's largest Q4 2017 buy was iShares MSCI Japan ETF: 520,841 shares worth $31.2M.
  • Parallax Volatility Advisers added most to iShares Russell 2000 ETF in Q4 2017, an estimated $118M increase.
  • Parallax Volatility Advisers's biggest Q4 2017 reduction was iShares MSCI EAFE ETF, cutting an estimated $227M.
  • Parallax Volatility Advisers fully exited Berkshire Hathaway Class A in Q4 2017, selling an estimated $19.5M.
  • Parallax Volatility Advisers's ten largest holdings make up 63% of its $73.6B portfolio in Q4 2017.
  • Parallax Volatility Advisers opened 2,351 new positions and closed 493 in Q4 2017.
  • Parallax Volatility Advisers's portfolio value rose 21% quarter-over-quarter to $73.6B.

Based on Parallax Volatility Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.